DEI TOS, ANGELO
 Distribuzione geografica
Continente #
NA - Nord America 35.300
AS - Asia 26.398
EU - Europa 11.896
AF - Africa 4.893
SA - Sud America 4.660
OC - Oceania 467
Continente sconosciuto - Info sul continente non disponibili 189
Totale 83.803
Nazione #
US - Stati Uniti d'America 32.701
SG - Singapore 7.695
VN - Vietnam 4.266
CN - Cina 4.103
HK - Hong Kong 3.134
BR - Brasile 2.728
IT - Italia 2.698
FR - Francia 1.028
DE - Germania 923
IN - India 880
FI - Finlandia 822
NL - Olanda 596
GB - Regno Unito 539
BD - Bangladesh 496
PL - Polonia 471
IQ - Iraq 461
JP - Giappone 435
RU - Federazione Russa 411
AR - Argentina 404
TR - Turchia 402
SE - Svezia 367
MX - Messico 304
PH - Filippine 291
ZA - Sudafrica 290
PK - Pakistan 281
AT - Austria 275
CA - Canada 271
SA - Arabia Saudita 269
ID - Indonesia 262
EC - Ecuador 252
ES - Italia 236
BJ - Benin 222
UZ - Uzbekistan 207
UA - Ucraina 205
VE - Venezuela 205
CO - Colombia 200
KR - Corea 195
MA - Marocco 194
IE - Irlanda 186
TN - Tunisia 173
CH - Svizzera 170
PE - Perù 170
KE - Kenya 168
MY - Malesia 167
TH - Thailandia 167
CI - Costa d'Avorio 166
CL - Cile 165
AL - Albania 164
PY - Paraguay 160
JO - Giordania 153
PS - Palestinian Territory 152
DZ - Algeria 150
RO - Romania 150
ET - Etiopia 148
SN - Senegal 148
AO - Angola 147
LB - Libano 145
MD - Moldavia 145
NP - Nepal 145
UY - Uruguay 145
CZ - Repubblica Ceca 142
BE - Belgio 141
IR - Iran 140
SK - Slovacchia (Repubblica Slovacca) 140
CR - Costa Rica 138
EG - Egitto 138
GT - Guatemala 137
KG - Kirghizistan 136
PT - Portogallo 135
RS - Serbia 135
AE - Emirati Arabi Uniti 134
DO - Repubblica Dominicana 133
PA - Panama 130
KZ - Kazakistan 129
JM - Giamaica 128
IL - Israele 127
LY - Libia 127
AZ - Azerbaigian 126
MN - Mongolia 126
BA - Bosnia-Erzegovina 125
HU - Ungheria 125
SI - Slovenia 124
EE - Estonia 123
GN - Guinea 122
YT - Mayotte 121
HN - Honduras 120
NI - Nicaragua 120
PR - Porto Rico 120
CV - Capo Verde 119
KH - Cambogia 119
LU - Lussemburgo 119
ZW - Zimbabwe 118
GF - Guiana Francese 117
TW - Taiwan 117
HR - Croazia 116
LV - Lettonia 116
BG - Bulgaria 115
BZ - Belize 115
GE - Georgia 115
AM - Armenia 114
Totale 78.245
Città #
Singapore 4.595
San Jose 4.322
Ashburn 4.189
Fairfield 3.721
Hong Kong 2.778
Chandler 1.569
Woodbridge 1.568
Seattle 1.449
Houston 1.410
Cambridge 1.281
Ho Chi Minh City 1.281
Wilmington 1.070
Hanoi 987
Los Angeles 853
Santa Clara 812
Ann Arbor 792
Beijing 718
Boardman 555
Helsinki 490
San Diego 471
Lauterbourg 460
New York 427
Princeton 394
Medford 375
Chicago 362
Munich 339
Guangzhou 310
Des Moines 284
Da Nang 278
Tokyo 269
São Paulo 260
Padova 251
Milan 237
Council Bluffs 231
Buffalo 230
Bytom 225
Cotonou 214
Tashkent 180
Vienna 180
Baghdad 179
Hefei 177
Roxbury 177
Orem 176
Shanghai 176
Haiphong 172
Frankfurt am Main 161
Abidjan 160
Amsterdam 159
Rome 155
London 154
Dakar 146
Nanjing 145
Dublin 141
Nairobi 141
Warsaw 138
Amman 134
Addis Ababa 128
Johannesburg 128
Nuremberg 122
Ulan Bator 122
Istanbul 121
Conakry 120
Luanda 120
Panama City 119
Managua 118
Turku 117
Bishkek 116
Baku 114
Lappeenranta 114
Montevideo 113
Montreal 112
Salt Lake City 112
Dallas 111
Phnom Penh 107
Harare 106
Jeddah 106
San José 106
Chennai 105
Kampala 105
Rio de Janeiro 105
Brooklyn 104
Castries 104
Dong Ket 104
Lahore 100
Praia 100
Dushanbe 98
Redondo Beach 98
Bridgetown 97
The Dalles 97
Tirana 97
Lima 96
Kigali 95
Yerevan 95
Riga 94
Willemstad 94
Libreville 93
Stockholm 93
Padua 91
Atlanta 90
Riyadh 90
Totale 47.785
Nome #
IMMUNOREACT 6: weak immune surveillance characterizes early-onset rectal cancer 446
Melanoma in Adolescents and Young Adults: Evaluation of the Characteristics, Treatment Strategies, and Prognostic Factors in a Monocentric Retrospective Study 337
Melanoma of Unknown Primary: Evaluation of the Characteristics, Treatment Strategies, Prognostic Factors in a Monocentric Retrospective Study 330
Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME) 327
Autoimmune gastritis: long-term natural history in naïve Helicobacter pylori-negative patients 321
Prognostic impact of FGFR2/3 alterations in patients with biliary tract cancers receiving systemic chemotherapy: the BITCOIN study 319
Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial 313
IMMUNOREACT 5: female patients with rectal cancer have better immune editing mechanisms than male patients, a cohort study 308
Tumor-stroma ratio, neoangiogenesis and prognosis in laryngeal carcinoma. A pilot study on preoperative biopsies and matched surgical specimens 305
Absence of disruptive TP53 mutations in high-risk human papillomavirus-driven neck squamous cell carcinoma of unknown primary 304
Reprogramming normal cells into tumour precursors requires ECM stiffness and oncogene-mediated changes of cell mechanical properties 301
Mismatch repair gene defects in sporadic colorectal cancer enhance immune surveillance 290
Class 1, 2 and 3 BRAF mutated metastatic colorectal cancer: a detailed clinical, pathological and molecular characterization 289
Plasma small-extracellular vesicles enriched in miR-122-5p promote disease aggressiveness in pediatric anaplastic large-cell lymphoma 288
Can Vascular Endothelial Growth Factors and CD34 Expression Implement NICE (Narrow-Band Imaging International Colorectal Endoscopic) Classification in Colorectal Polypoid Lesion Diagnosis? 285
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 284
Per- and polyfluoroalkyl substances (PFAS) exposure in melanoma patients: a retrospective study on prognosis and histological features 277
Association of cldn18 protein expression with clinicopathological features and prognosis in advanced gastric and gastroesophageal junction adenocarcinomas 276
Altitude Effect on Cutaneous Melanoma Epidemiology in the Veneto Region (Northern Italy): A Pilot Study 272
Histology of the spleen in Immune Thrombocytopenia: clinical-pathological characterization and prognostic implications 265
The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives 265
mTOR pathway and somatostatin receptors expression intratumor-heterogeneity in ileal NETs 264
Deregulation of dicer and mir-155 expression in liposarcoma 263
KIT, PDGFRA, and BRAF mutational spectrum impacts on the natural history of imatinib-naive localized GIST 262
Idiopathic retroperitoneal fibrosis: Clinicopathologic features and differential diagnosis 260
Multi-Design Differential Expression Profiling of COVID-19 Lung Autopsy Specimens Reveals Significantly Deregulated Inflammatory Pathways and SFTPC Impaired Transcription 258
Biological fate of tissue-engineered porcine valvular conduits xenotransplanted in the sheep thoracic aorta 257
Braf mutation in interdigitating dendritic cell sarcoma: a case report and review of the literature 255
Low miR-214-5p Expression Correlates With Aggressive Subtypes of Pediatric ALCL With Non-Common Histology 255
Direct Costs of Care for Adults with Soft Tissue Sarcomas: A Population-Based Study 255
Predictors of neoplastic progression in gastroesophageal lesions indefinite for dysplasia 253
MGMT promoter methylation and correlation with protein expression in primary central nervous system lymphoma 253
Rare cancers are not so rare: The rare cancer burden in Europe 250
Quality of surgery and neoadjuvant combined therapy in the ISG-GEIS trial on soft tissue sarcomas of limbs and trunk wall 248
TERT promoter hotspot mutations and their relationship with TERT levels and telomere erosion in patients with head and neck squamous cell carcinoma 248
Rabbit monoclonal antibodies: A comparative study between a novel category of immunoreagents and the corresponding mouse monoclonal antibodies 247
Cross-talk between GLI transcription factors and FOXC1 promotes T-cell acute lymphoblastic leukemia dissemination 247
Imatinib-Sensitizing KIT Mutation in a Carney-Stratakis-Associated GI Stromal Tumor 246
Colorectal polypoid lesions and expression of vascular endothelial growth factor in a consecutive series of endoscopic and surgical patients 246
Extraskeletal Myxoid Chondrosarcoma: clinical and molecular characteristics and outcomes of patients treated at two Institutions 243
Incidental lymphomas in surgical pathology: diagnostic clues and clinical-pathological correlations 243
Anaplastic ependymoma of the third ventricle 242
Epstein-Barr virus associated gastric dysplasia: a new rare entity? 242
Papillary Thyroid Carcinoma: Molecular Distinction by MicroRNA Profiling 240
Detection of HPV16/18 E6 Oncoproteins in Head and Neck Squamous Cell Carcinoma Using a Protein Immunochromatographic Assay 239
"While there is p57, there is hope." The past and the present of diagnosis in first trimester abortions: Diagnostic dilemmas and algorithmic approaches. A review 239
CD23 expression in lymphoplasmacytic lymphoma: Clinical–pathological and biological correlations 238
CK2β-regulated signaling controls B cell differentiation and function 237
Utility of the immunohistochemical detection of FLI-1 expression in round cell and vascular neoplasm using a monoclonal antibody 237
Management of metastatic retroperitoneal sarcoma: a consensus approach from the Trans-Atlantic Retroperitoneal Sarcoma Working Group (TARPSWG) 237
Pembrolizumab Activity in Recurrent High-Grade Gliomas with Partial or Complete Loss of Mismatch Repair Protein Expression: A Monocentric, Observational and Prospective Pilot Study 236
Liver histopathology in COVID-19 patients: A mono-Institutional series of liver biopsies and autopsy specimens 235
Thrombopoietin receptor agonists increase splenic regulatory T-cell numbers in immune thrombocytopenia 234
Tumor genotype, location and malignant potential shape the immunogenicity of primary, untreated Gastrointestinal Stromal Tumors 233
Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test 232
Gastric metastases of breast cancer: Histopathological and molecular characterization of a single Institution case series 232
Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: A retrospective analysis 230
Evolution of Dermatofibrosarcoma protuberans (DFSP) to DFSP-derived fibrosarcoma (FS-DFSP): an event marked by epithelial mesenchymal transition-like process and 22q loss 228
A Pediatric Intra-Axial Malignant SMARCB1-Deficient Desmoplastic Tumor Arising in Meningioangiomatosis 228
Clinical recommendations for treatment of localized angiosarcoma: A consensus paper by the Italian Sarcoma Group 227
Myogenic differentiation and histologic grading are major prognostic determinants in retroperitoneal liposarcoma 227
Detection of Molecular Residual Disease Using Personalized Circulating Tumor DNA Assay in Patients With Colorectal Cancer Undergoing Resection of Metastases 227
The molecular landscape of primary acral melanoma: A multicenter study of the italian melanoma intergroup (imi) 227
Innate Immunity Activation in Newly Diagnosed Ileocolonic Crohn's Disease: A Cohort Study 226
Interferon-Gamma and Tumor Necrosis Factor-Related Weak Inducer of Apoptosis Expression in Neoangiogenesis in Colorectal Polypoid Lesions 226
MLH1 Deficiency Down-Regulates TLR4 Expression in Sporadic Colorectal Cancer 226
MLH1 gene promoter methylation status partially overlaps with CpG methylator phenotype (CIMP) in colorectal adenocarcinoma 226
Impact of DNA mismatch repair proteins deficiency on number and ratio of lymph nodal metastases in colorectal adenocarcinoma 225
Digital pathology world tour 224
Spermatic Cord Sarcoma: A 20-Year Single-Institution Experience 224
Pharmacological modulation of Kv1.3 potassium channel selectively triggers pathological B lymphocyte apoptosis in vivo in a genetic CLL model 224
Enhancing diagnosis of Hirschsprung’s disease using deep learning from histological sections of post pull-through specimens: preliminary results 223
Molecular profiling of appendiceal serrated lesions, polyps and mucinous neoplasms: a single-centre experience 223
Concomitant KIT/BRAF and PDGFRA/BRAF mutations are rare events in gastrointestinal stromal tumors 223
Activity of sunitinib in extraskeletal myxoid chondrosarcoma 222
Clear cell sarcoma of the ileum: report of a case and review of the literature. 221
Case report: Complete pathologic response with first-line immunotherapy combination in a young adult with massive liver dissemination of mismatch repair-deficient metastatic colorectal cancer: Immunological and molecular profiling 220
Atypical cystic meningioma overexpressing AQP1 in early infancy: case report with literature review. 220
Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma: A Multi-institutional Case Series 219
Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group 219
A bone-based 3D scaffold as an in-vitro model of microenvironment–DLBCL lymphoma cell interaction 217
Long-term survival, prevalence, and cure of cancer: A population-based estimation for 818 902 Italian patients and 26 cancer types 217
Lymph node core needle biopsy for the diagnosis of lymphoproliferative disorders: a word of caution 217
Lymph node core needle biopsy in lymphoproliferative disorders - Authors' reply to Al-Abbadi and colleagues 217
Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working Group 216
KRAS G12C Metastatic Colorectal Cancer: Specific Features of a New Emerging Target Population 216
The rarest of rare thymic lesions: A 10-year surgical pathology experience 216
Metachronous colorectal cancer have a similar microsatellite instability frequency but a lower infiltration of lymphomononuclear cells than primary lesions 216
Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating Lymphocytes 215
Proinsulin-expressing dendritic cells in type 2 neuropathic diabetic patients with and without foot lesions 214
Are IDH1 R132 Mutations Associated With Poor Prognosis in Patients With Chondrosarcoma of the Bone? 213
Comparative assessment of antitumor effects and autophagy induction as a resistance mechanism by cytotoxics and EZH2 inhibition in INI1-negative epithelioid sarcoma patient-derived xenograft 213
Predictors of Splenectomy Response in Immune Thrombocytopenia: A Multicentric Italian Study 212
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial 212
PML expression in soft tissue sarcoma: prognostic and predictive value in alkylating agents/antracycline-based first line therapy 211
Prognostic factors in phyllodes tumours of the breast: retrospective study on 166 consecutive cases 211
Transcriptome sequencing identifies ETV6-NTRK3 as a gene fusion involved in GIST 210
Rare neuroendocrine tumours: Results of the surveillance of rare cancers in Europe project 209
CIC-DUX4 Fusion-Positive Round Cell Sarcomas of soft tissue and bone: a single institution morphologic and molecular analysis of 7 cases 208
Benign cartilaginous tumors of bone: From morphology to somatic and germ-line genetics 208
Totale 24.661
Categoria #
all - tutte 234.382
article - articoli 231.516
book - libri 940
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.926
Totale 468.764


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021720 0 0 0 0 0 0 0 0 0 0 324 396
2021/20225.366 214 524 731 301 364 308 328 524 333 161 455 1.123
2022/20233.391 793 359 73 329 433 354 44 224 420 105 185 72
2023/20242.628 81 283 261 167 158 269 214 135 94 372 352 242
2024/202511.537 93 687 580 450 1.341 398 557 971 1.161 603 1.726 2.970
2025/202650.798 2.283 4.032 7.618 9.141 4.469 2.082 7.619 4.009 5.127 2.820 1.598 0
Totale 84.516